Okhuysen PC, Ramesh MS, Louie T, Kiknadze N, et al. A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response. Clin Infect Dis 2024;78:1462-1472.
PMID: 38305378